Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New ultrasound measure may spot heart risk after chest surgery

NCT ID NCT05060302

Knowledge-focused Sponsor: Centre Hospitalier Universitaire, Amiens Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a new heart ultrasound measurement can predict serious heart complications after chest surgery. Researchers followed 191 adults who had lung surgery and performed heart ultrasounds before surgery, two days after, and fifteen days after. They tracked whether patients had heart problems like irregular heartbeat or heart failure within 30 days of surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a better way to predict heart complications after chest surgery, helping doctors identify high-risk patients earlier.
What could go wrong
This is a small, single-center pilot study, so results may not apply to all patients. The new measurement technique is still being tested and may not prove to be better than existing methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

191 people

The number who actually took part.

Started

Sep 2021

Finished

Jan 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patient (\>18 years) * Patient hospitalized at the Amiens University Hospital for scheduled thoracic surgery (lobectomy, pneumonectomy, wedge resection). * Surgery by thoracotomy or video-assisted thoracic surgery * Information of the patient and collection of his non-opposition Exclusion Criteria: * Patient with poor echogenicity on TTE not allowing evaluation of 2D-STE or conventional parameters of the RV. * Patient with a rapid supraventricular rhythm disorder (HR \> 100) at the time of TTE * Patient under mechanical ventilation * Patient under extracorporeal membrane oxygenation * Patients under guardianship or legal protection * Patients whose clinical condition does not allow for their non-opposition * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Right ventricle are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Right ventricle Thoracic surgery

Contacts and locations

Locations

  • CHU Amiens Picardie

    Amiens, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.